And when those assets become intertwined with health products, telehealth prescriptions, and GLP-1 pipeline marketing, consumers stop making decisions based on medical reality and start making them based on synthetic fantasy
GLP-1 medications are still relatively new, so not all long-term side effects are known, but they are found to be generally safe for those prescribed
Because rapid jumps to maintenance levels dramatically increase nausea, vomiting and pancreatitis risk, while the stepped approach lets the body adapt
Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program
These integrated actions position incretin-based therapies as uniquely suited to address the complex, multifactorial pathophysiology of MASLD [19]